These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 36365243)

  • 1. Protein and Gene Delivery Systems for Neurodegenerative Disorders: Where Do We Stand Today?
    Siafaka PI; Okur ME; Erim PD; Çağlar EŞ; Özgenç E; Gündoğdu E; Köprülü REP; Karantas ID; Üstündağ Okur N
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36365243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
    Teixeira MI; Lopes CM; Amaral MH; Costa PC
    Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform.
    Pinto M; Silva V; Barreiro S; Silva R; Remião F; Borges F; Fernandes C
    Ageing Res Rev; 2022 Aug; 79():101658. PubMed ID: 35660114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid nanocarriers loaded with natural compounds: Potential new therapies for age related neurodegenerative diseases?
    Soares TB; Loureiro L; Carvalho A; Oliveira MECDR; Dias A; Sarmento B; Lúcio M
    Prog Neurobiol; 2018 Sep; 168():21-41. PubMed ID: 29641983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology for CNS delivery of bio-therapeutic agents.
    Shah L; Yadav S; Amiji M
    Drug Deliv Transl Res; 2013 Aug; 3(4):336-51. PubMed ID: 23894728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy and apoptosis dysfunction in neurodegenerative disorders.
    Ghavami S; Shojaei S; Yeganeh B; Ande SR; Jangamreddy JR; Mehrpour M; Christoffersson J; Chaabane W; Moghadam AR; Kashani HH; Hashemi M; Owji AA; Łos MJ
    Prog Neurobiol; 2014 Jan; 112():24-49. PubMed ID: 24211851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Focused Ultrasound-mediated Drug Delivery in Humans - a Path Towards Translation in Neurodegenerative Diseases".
    Wasielewska JM; White AR
    Pharm Res; 2022 Mar; 39(3):427-439. PubMed ID: 35257286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligonucleotide therapeutics in neurodegenerative diseases: the case of polyglutamine disorders.
    Silva AC; Lobo DD; Martins IM; Lopes SM; Henriques C; Duarte SP; Dodart JC; Nobre RJ; Pereira de Almeida L
    Brain; 2020 Feb; 143(2):407-429. PubMed ID: 31738395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genistein: A focus on several neurodegenerative diseases.
    Li R; Robinson M; Ding X; Geetha T; Al-Nakkash L; Broderick TL; Babu JR
    J Food Biochem; 2022 Jul; 46(7):e14155. PubMed ID: 35460092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current advances in the development of novel polymeric nanoparticles for the treatment of neurodegenerative diseases.
    Cano A; Sánchez-López E; Ettcheto M; López-Machado A; Espina M; Souto EB; Galindo R; Camins A; García ML; Turowski P
    Nanomedicine (Lond); 2020 May; 15(12):1239-1261. PubMed ID: 32370600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines.
    Rajpoot K
    Curr Drug Targets; 2020; 21(8):819-836. PubMed ID: 31906836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Gene Therapy Towards Treating Neurodegenerative Disea ses Employing Polymeric Nanosystems.
    Bangde P; Atale S; Dey A; Pandit A; Dandekar P; Jain R
    Curr Gene Ther; 2017; 17(2):170-183. PubMed ID: 28494742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases.
    Zang X; Chen S; Zhu J; Ma J; Zhai Y
    Front Aging Neurosci; 2022; 14():872134. PubMed ID: 35547626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA double-strand breaks: a potential therapeutic target for neurodegenerative diseases.
    Thadathil N; Hori R; Xiao J; Khan MM
    Chromosome Res; 2019 Dec; 27(4):345-364. PubMed ID: 31707536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Patent Advances for Neurodegenerative Disorders and its Treatment.
    Kumar B; Sharma D
    Recent Pat Drug Deliv Formul; 2017; 11(3):158-172. PubMed ID: 29032765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Proteomic Tools in Modern Nanotechnological Approaches Towards Effective Management of Neurodegenerative Disorders.
    Ali A; Sheikh IA; Mirza Z; Gan SH; Kamal MA; Abuzenadah AM; Damanhouri GA; Ashraf GM
    Curr Drug Metab; 2015; 16(5):376-88. PubMed ID: 25495738
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.